Omeros (OMER) EBIT Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Omeros (OMER) EBIT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15,850.00 |
| Mar 31, 2026 | 3,895.00 |
| Jun 30, 2022 | -30,099.00 |
| Mar 31, 2022 | -39,713.00 |
| Dec 31, 2021 | -4,716.00 |
| Sep 30, 2021 | -2,611.00 |
| Jun 30, 2021 | -4,900.00 |
| Mar 31, 2021 | 4,715.00 |
| Dec 31, 2020 | -4,780.00 |
| Sep 30, 2020 | 49,486.00 |
| Jun 30, 2020 | 29,642.00 |
| Mar 31, 2020 | 452,054.00 |
| Dec 31, 2019 | 1.10 Mn |
| Sep 30, 2019 | 796,843.00 |
| Jun 30, 2019 | 3.82 Mn |
| Mar 31, 2019 | 1.56 Mn |
| Dec 31, 2018 | 814,213.00 |
| Sep 30, 2018 | 608,494.00 |
| Jun 30, 2018 | 755,003.00 |
| Mar 31, 2018 | -82,857.00 |